Request Trial
shutterstock_647031994_romanr
romanr / Shutterstock.com
22 February 2019Americas

ResMed and Fisher & Paykel settle patent disputes

American medical device maker  ResMed and New Zealand-based competitor  Fisher & Paykel have agreed to settle a global patent dispute over medical devices.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Medtech company sues over seven patents for incontinence products
13 May 2026   PureWick claims that two rivals infringed its external catheter and urine-management technology in their medical devices.
Americas
10x Genomics settles suit with rival and targets DNA sequencing startup
12 May 2026   The dominant player in the spatial biology market has sued a San Diego-based life sciences company over its genetic analysis technology, as another lawsuit in its patent litigation campaign approaches conclusion.
Americas
Trade secrets, AI and the new scrutiny of big damages awards
11 May 2026   Trade secret filings in the US reached an all-time high in 2025—particularly those relating to AI. Jeff Farrow of Michelman Robinson explains the principles that courts are increasingly applying, and how companies on both sides of the ‘v’ can prepare.


Editor's picks

From the courtroom: Hikma v Amarin SCOTUS oral arguments
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026

Editor's picks

Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026

More features

Medtech company sues over seven patents for incontinence products
10x Genomics settles suit with rival and targets DNA sequencing startup
Trade secrets, AI and the new scrutiny of big damages awards
WATCH: Interview with Mythili Markowski, director at Regeneron
IP in the deal room: The risks that bite before, during and after closing
Teva can pursue monopoly claims over rival’s ‘exclusive pharmacy deal’
Five generations at work: How teams are bridging the gap
Kilpatrick adds tech patent litigator and China expert to Chicago office